Invesco Preferred ETF vs 22nd Century Group Inc — how do they compare? Invesco Preferred ETF trades at $10.38, while 22nd Century Group Inc trades at $2.17 (market cap $1.50M). Which is the better fit depends on your goals.
| PGX | XXII | |
|---|---|---|
52-Week High | $11.87 | $594.00 |
52-Week Low | $10.46 | $2.13 |
Market Cap | — | $1.50M |
Sector | — | Technology |
Enterprise Value | — | -$2.81M |
Signals from Pluang's Aura AI — not financial advice
PGX trades at $10.49 with no recent price movement, showing technical bearish signals from moving averages but bullish momentum from oscillators. The stock faces resistance at $11 with support at $10. Recent corporate actions include scheduled dividends for mid-2026. Financial ratios remain unavailable, limiting fundamental assessment.
The outlook is mixed with technical indicators conflicting between bearish trend and oversold bounce potential. Key risks include limited financial transparency and market sentiment challenges. Investment opportunity hinges on future financial disclosures and dividend execution stability amid current technical uncertainty.
XXII trades at $2.29, down 4.58% today, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a Q2 2026 EPS miss of -15.6 versus -6 expected, with negative gross and net income margins. Recent news highlights VLN brand expansion and a 20:1 reverse stock split effective June 12, 2026.
Outlook is challenged by persistent losses and high cash burn, though analyst consensus is 75% buy. Key risks include execution on commercialization and profitability turnaround. The stock's low valuation multiples may attract speculative interest if operational improvements materialize.
Trailing returns across standard periods
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →